We are live on ! Find out more
KCM

Kingdon Capital Management Portfolio holdings

AUM $911M
1-Year Est. Return 51.11%
This Fund
S&P 500
This Quarter Est. Return
+7.31%
1 Year Est. Return
+51.11%
3 Year Est. Return
+185.44%
5 Year Est. Return
+284.29%
10 Year Est. Return
+2,022.7%
AUM
$1.02B
AUM Growth
+$269M
Cap. Flow
+$233M
Cap. Flow %
22.87%
Top 10 Hldgs %
44.41%
Holding
92
New
31
Increased
16
Reduced
12
Closed
24

Top Buys

Rank Stock Value
1
FCX icon
Freeport-McMoran
FCX
+$36.6M
2
BABA icon
Alibaba
BABA
+$25.9M
3
ZBRA icon
Zebra Technologies
ZBRA
+$24.4M
4
ARMK icon
Aramark
ARMK
+$21.1M
5
COTY icon
Coty
COTY
+$20.3M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$24M
2
SGI
Somnigroup International
SGI
+$20.4M
3
KEYS icon
Keysight
KEYS
+$20.2M
4
RCL icon
Royal Caribbean
RCL
+$17.4M
5
RH icon
RH
RH
+$16.4M

Sector Composition

Rank Sector Weight
1 Healthcare 25.18%
2 Industrials 11.95%
3 Technology 10.39%
4 Consumer Discretionary 9.94%
5 Materials 6.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IONS icon
76
PUT
Ionis Pharmaceuticals
IONS
$9.07B
-100,000
Closed -$8.12M
KEYS icon
77
Keysight
KEYS
$57B
-231,794
Closed -$20.2M
LW icon
78
Lamb Weston
LW
$7.24B
-196,260
Closed -$14.7M
LYFT icon
79
Lyft
LYFT
$6.26B
-5,500
Closed -$431K
RH icon
80
RH
RH
$3.54B
-159,285
Closed -$16.4M
TECK icon
81
Teck Resources
TECK
$31.4B
-549,191
Closed -$12.7M
TMO icon
82
Thermo Fisher Scientific
TMO
$208B
-57,603
Closed -$15.8M
TROX icon
83
Tronox
TROX
$922M
-495,195
Closed -$6.51M
TSN icon
84
Tyson Foods
TSN
$20.7B
-227,230
Closed -$15.8M
SGI
85
Somnigroup International
SGI
$14.3B
-1,417,236
Closed -$20.4M
IMGN
86
CALL
DELISTED
Immunogen Inc
IMGN
-200,000
Closed -$542K
ICPT
87
PUT
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
-100,000
Closed -$11.2M
BOLD
88
DELISTED
Audentes Therapeutics, Inc
BOLD
-108,031
Closed -$4.21M
GTYHW
89
DELISTED
GTY Technology Holdings, Inc. Warrants
GTYHW
-400,000
Closed -$241K
CELG
90
DELISTED
Celgene Corp
CELG
-254,244
Closed -$24M
BHVN
91
CALL
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
-100,000
Closed -$5.15M

Similar funds

Kingdon Capital Management's Q2 2019 Portfolio in Review

As of Q2 2019, Kingdon Capital Management held 92 positions worth $1.02B, up 36% from $748M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Kingdon Capital Management deployed $233M of net new capital in Q2 2019, opening 31 new positions and adding to 16 existing holdings. Its largest new stake was Freeport-McMoran: 3,140,882 shares worth $36.5M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 31% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was Royal Caribbean, an estimated $17.4M trimmed.

  • Kingdon Capital Management's largest Q2 2019 buy was Freeport-McMoran: 3,140,882 shares worth $36.5M.
  • Kingdon Capital Management added most to Biohaven Pharmaceutical Holding Company Ltd. in Q2 2019, an estimated $8.86M increase.
  • Kingdon Capital Management's biggest Q2 2019 reduction was Royal Caribbean, cutting an estimated $17.4M.
  • Kingdon Capital Management fully exited Celgene Corp in Q2 2019, selling an estimated $24M.
  • Kingdon Capital Management's ten largest holdings make up 44% of its $1.02B portfolio in Q2 2019.
  • Kingdon Capital Management opened 31 new positions and closed 24 in Q2 2019.
  • Kingdon Capital Management's portfolio value rose 36% quarter-over-quarter to $1.02B.

Based on Kingdon Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.